MLYS

NASDAQStock

Mineralys Therapeutics, Inc.

$26.52-0.47 (-1.74%)

52-Week Range

$11.77
$47.33

Key Stats

Market Cap

1.8B

P/E Ratio

Dividend Yield

Beta

0.57

Volume

883.8K

Avg Volume

1.2M

Performance

1M

-2.21%

3M

-25.07%

6M

-27.87%

YTD

-24.42%

1Y

+89.80%

3Y

+75.49%

5Y

+46.37%

Price Chart

ETF Exposure

MLYS is held by 101 ETFs

ETFFund NameWeight
WSMLiShares MSCI World Small-Cap ETF0.01%
WSML.LiShares MSCI World Small Cap UCITS ETF0.01%
OMFSInvesco Russell 2000 Dynamic Multifactor ETF0.01%
WDSC.LState Street SPDR MSCI World Small Cap UCITS ETF (Acc)0.01%
WOSC.LState Street SPDR MSCI World Small Cap UCITS ETF (Acc)0.01%
ZPRS.DEState Street SPDR MSCI World Small Cap UCITS ETF (Acc)0.01%
DFASDimensional - US Small Cap ETF0.01%
SMMDiShares Russell 2500 ETF0.01%
DXUVDimensional - US Vector Equity ETF0.01%
HDGProShares - Hedge Replication ETF0.01%
ONEQFIDELITY NASDAQ COMPOSITE INDEX ETF0.01%
SCHBSchwab U.S. Broad Market ETF0.00%
USFM.LUBS MSCI USA Select Factor Mix UCITS ETF USD dis0.00%
ZPRV.DEState Street SPDR MSCI USA Small Cap Value Weighted UCITS ETF0.00%
DFAUDimensional - US Core Equity Market ETF0.00%
DFUSDimensional - US Equity Market ETF0.00%
ITOTiShares Core S&P Total U.S. Stock Market ETF0.00%
IWViShares Russell 3000 ETF0.00%
VTHRVanguard Russell 3000 ETF0.00%
VTIVanguard Total Stock Market ETF0.00%
VUN.TOVanguard U.S. Total Market Index ETF0.00%
VUS.TOVanguard U.S. Total Market Index ETF (CAD-hedged)0.00%
AVSCAvantis U.S. Small Cap Equity ETF0.00%
DCORDimensional - US Core Equity 1 ETF0.00%
DFSUDimensional - US Sustainability Core 1 ETF0.00%
EAOAiShares ESG Aware 80/20 Aggressive Allocation ETF0.00%
EAOMiShares ESG Aware 40/60 Moderate Allocation ETF0.00%
EAORiShares ESG Aware 60/40 Balanced Allocation ETF0.00%
ITDEiShares LifePath Target Date 2045 ETF0.00%
ITDFiShares LifePath Target Date 2050 ETF0.00%
ITDGiShares LifePath Target Date 2055 ETF0.00%
ITDHiShares LifePath Target Date 2060 ETF0.00%
ITDIiShares LifePath Target Date 2065 ETF0.00%
ITDJiShares LifePath Target Date 2070 ETF0.00%
VEQT.TOVanguard All-Equity ETF Portfolio0.00%
XEQT.TOiShares Core Equity ETF Portfolio0.00%
XUU.TOiShares Core S&P U.S. Total Market Index ETF0.00%
AVTMAvantis Total Equity Markets ETF 10.00%
AVUSAvantis U.S. Equity ETF0.00%
DFACDimensional - US Core Equity 2 ETF0.00%
EAOKiShares ESG Aware 30/70 Conservative Allocation ETF0.00%
ITDBiShares LifePath Target Date 2030 ETF0.00%
ITDCiShares LifePath Target Date 2035 ETF0.00%
ITDDiShares LifePath Target Date 2040 ETF0.00%
LSLTPacer Salt Low truBeta US Market ETF0.00%
SLTPacer Salt High truBeta US Market ETF0.00%
TRPLPacer Metaurus US Large Cap Dividend Multiplier 300 ETF0.00%
VCNS.TOVanguard Conservative ETF Portfolio0.00%
VETSPacer Military Times Best Employers ETF0.00%
VIRSPacer BioThreat Strategy ETF0.00%
PreviousPage 2 of 3Next

About MLYS ETF Exposure

Mineralys Therapeutics, Inc. (MLYS) is held by 101 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 1.8B, MLYS is a widely held institutional stock. The stock currently trades at $26.52. Investors can gain exposure to MLYS through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold MLYS, sorted by portfolio weight.